Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.
Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- Check5 days agoChange DetectedFooter revision notice updated to Revision: v3.3.3. The HHS Vulnerability Disclosure link and the old Revision: v3.3.2 notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the ClinicalTrials.gov page. The core study details remain unchanged.SummaryDifference0.0%
- Check33 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check41 days agoChange DetectedNotice about government funding and NIH operating status was removed from the page.SummaryDifference0.3%
- Check55 days agoChange DetectedOnly minor UI/layout adjustments to headers and page structure are evident, with no substantive changes to study details (title, purpose, endpoints, eligibility criteria, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check84 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference3%
Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.